Infectious Complications of Novel Multiple Sclerosis Therapies.

about

Both cladribine and alemtuzumab may effect MS via B-cell depletion

P2860

Q38720045-E674A1D5-2B93-497E-B62A-18BCA9DB5399

P2860

Infectious Complications of Novel Multiple Sclerosis Therapies.

Item

http://www.wikidata.org/entity/Q38944786

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Infectious Complications of Novel Multiple Sclerosis Therapies.

@en

type

Item

label

Infectious Complications of Novel Multiple Sclerosis Therapies.

@en

prefLabel

Infectious Complications of Novel Multiple Sclerosis Therapies.

@en

P1476

Infectious Complications of Novel Multiple Sclerosis Therapies.

@en

P2093

S N Levin

http://www.w3.org/2001/XMLSchema#string

T B Kaplan

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects

Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11908-017-0562-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28233190

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

Infectious Complications of Novel Multiple Sclerosis Therapies.

about

P2860

P2860

Infectious Complications of Novel Multiple Sclerosis Therapies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921